Form 8-K - Current report:
SEC Accession No. 0001079973-21-000914
Filing Date
2021-09-15
Accepted
2021-09-15 13:12:25
Documents
14
Period of Report
2021-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbgl_8k-ixbrl.htm   iXBRL 8-K 24183
2 EXHIBIT 17.1 ex17x1.htm EX-17.1 413
3 GRAPHIC ex17x1.jpg GRAPHIC 58293
  Complete submission text file 0001079973-21-000914.txt   277593

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cbgl-20210910.xsd EX-101.SCH 3051
5 XBRL LABEL FILE cbgl-20210910_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cbgl-20210910_pre.xml EX-101.PRE 22376
7 EXTRACTED XBRL INSTANCE DOCUMENT cbgl_8k-ixbrl_htm.xml XML 3579
Mailing Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071
Business Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071 (310) 986-4929
CANNABIS GLOBAL, INC. (Filer) CIK: 0001413488 (see all company filings)

EIN.: 831754057 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-56141 | Film No.: 211254994
SIC: 2836 Biological Products, (No Diagnostic Substances)